论文信息 - Could KL-6 levels in COVID-19 help to predict lung disease? - 字舞流文

Could KL-6 levels in COVID-19 help to predict lung disease?

M. Moutschen | E. Cavalier | B. Misset | J. Guiot | A. Frix | M. Henket | R. Louis | B. Duysinx | F. Vaillant | A. Ladang | L. Schoneveld

[1] A. Sethi,et al. Impact of Coronavirus disease (COVID-19) pandemic on health professionals , 2020, Pakistan journal of medical sciences.

[2] B. Hill. The COVID-19 pandemic. , 2020, British journal of nursing.

[3] Y. Leng,et al. Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19 , 2020, Respiratory Medicine.

[4] K. Brown,et al. Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype. , 2020, Chest.

[5] C. Tong,et al. Lactate dehydrogenase, a Risk Factor of Severe COVID-19 Patients , 2020, medRxiv.

[6] Xiao Chen,et al. Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19 , 2020, Journal of medical virology.

[7] J. Escrivá,et al. MUC1 intracellular bioactivation mediates lung fibrosis , 2019, Thorax.

[8] M. Malaise,et al. Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature , 2019, Rheumatology.

[9] M. Frieman,et al. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection , 2017, Journal of Virology.

[10] J. Guiot,et al. Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2017, Lung.

[11] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..